ARDX
Ardelyx Inc
Price:  
3.39 
USD
Volume:  
5,113,499.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx WACC - Weighted Average Cost of Capital

The WACC of Ardelyx Inc (ARDX) is 8.1%.

The Cost of Equity of Ardelyx Inc (ARDX) is 7.75%.
The Cost of Debt of Ardelyx Inc (ARDX) is 10.30%.

Range Selected
Cost of equity 6.40% - 9.10% 7.75%
Tax rate -% - 0.30% 0.15%
Cost of debt 7.00% - 13.60% 10.30%
WACC 6.5% - 9.8% 8.1%
WACC

Ardelyx WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 9.10%
Tax rate -% 0.30%
Debt/Equity ratio 0.17 0.17
Cost of debt 7.00% 13.60%
After-tax WACC 6.5% 9.8%
Selected WACC 8.1%

Ardelyx's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for Ardelyx:

cost_of_equity (7.75%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.55) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.